INDP - Indaptus Therapeutics, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
4.16 -0.3 (-7.21%)	---	---	0.0 (0.0%)	0.03 (0.62%)	-0.13 (-3.21%)	0.02 (0.52%)	0.02 (0.52%)

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.32
Diluted EPS:: -0.32
Basic P/E:: -12.0628
Diluted P/E:: -12.0628
RSI(14) 1m:: 100.0
VWAP:: 3.86
RVol:: 0.1276

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	3.92 +0.05 (+1.29%)	Oct 15 15:59
1m	Price increase 1m	3.87 +0.04 (+1.13%)	Oct 15 15:43
1m	Price increase 1m	3.88 +0.06 (+1.45%)	Oct 15 13:46
1m	Price decrease 1m	3.9 -0.05 (-1.27%)	Oct 15 11:48
1m	Price increase 1m	4.09 +0.14 (+3.54%)	Oct 15 10:57